Noble Financial Keeps Harte-Hanks (HHS) at 'Buy'; Thinks Trillium Could be Worth Way More than Previously Expected
Tweet Send to a Friend
Noble Financial affirms Harte-Hanks (NYSE: HHS) at Buy with a target price of $10 following a recent meeting with the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
